ECT vs. aripiprazole for schizophrenia on clozapine
Treatments studied
Part of Mental health clinical trials.
This study compares maintenance electroconvulsive therapy (ECT) to the medication aripiprazole for people whose schizophrenia has not improved enough with clozapine. The goal is to see which approach works better for continued treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with schizophrenia that is resistant to clozapine.
- You are currently taking clozapine.
- You are not already receiving ECT or aripiprazole.
- You do not have a history of substance abuse or dependence.
- You have a legal representative who can sign a consent form for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if regular electroconvulsive therapy (ECT) can help people whose schizophrenia has not improved with clozapine or who cannot take clozapine. Researchers will see if maintenance ECT helps prevent symptoms from returning.
This study compares two medications, carliprazine and aripiprazole, to see which works better for people having an acute (sudden worsening) episode of schizophrenia. If you qualify, you will receive one of these pills for several weeks, and the doctors will check your symptoms closely to see how you respond.
This trial tests whether clozapine can reduce repeat violent behavior in people with schizophrenia or schizoaffective disorder. Participants are randomly assigned to clozapine or usual care to see which approach works better for preventing violence.
This study tests how well a new aripiprazole injection works in your body compared to a standard version. You'll receive injections while your schizophrenia symptoms are stable, and researchers will measure drug levels in your blood to ensure the new version works the same way.
This study looks at long-acting (extended-release) antipsychotic medicine options in people with schizophrenia, compared with regular tablets. You may be able to join if you were already part of a related earlier study or its real-world follow-up.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
Hear when a new Clozapine Resistant Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.